## Clinical Diagnosis: Niemann-Pick Disease Type A **Key Point:** Niemann-Pick disease Type A is an acute neuronopathic form of sphingomyelinase deficiency, characterized by rapid neurodegeneration, cherry-red spots, hepatosplenomegaly, and sea-blue histiocytes in bone marrow. ### Niemann-Pick Disease: Classification and Features | Type | Enzyme | Age of Onset | CNS Involvement | Hepatosplenomegaly | Cherry-Red Spot | Lifespan | |------|--------|--------------|-----------------|-------------------|-----------------|----------| | **Type A** | Sphingomyelinase ↓↓ | 3–6 months | Severe, progressive | Yes | Yes | <3 years | | **Type B** | Sphingomyelinase ↓ | Childhood | Absent or mild | Yes | Rare | Normal/near-normal | | **Type C** | Cholesterol transport | Childhood–adulthood | Variable | Yes | Rare | Variable | | **Type D** | Cholesterol transport | Childhood | Variable | Yes | Rare | Variable | **High-Yield:** Type A is the most severe form with rapid onset in infancy and death by age 2–3 years. Type B is the chronic non-neuronopathic form with better prognosis. ### Pathognomonic Features in This Case 1. **Cherry-red spot on macula** — caused by accumulation of sphingomyelin in retinal ganglion cells; the fovea appears red against the pale, edematous surrounding retina. This is a hallmark of Type A Niemann-Pick disease and other storage disorders affecting the retina (e.g., GM1 gangliosidosis, sialidosis). 2. **Severe developmental regression** — indicates rapid CNS involvement; neurodegeneration begins in infancy and progresses rapidly. 3. **Seizures and hypotonia** — reflect widespread neuronal storage and dysfunction. 4. **Sea-blue histiocytes** — macrophages engorged with sphingomyelin, giving a characteristic blue-green appearance on Wright-Giemsa staining; highly specific for Niemann-Pick disease. 5. **Severely reduced sphingomyelinase activity** — confirms the enzymatic defect; this enzyme normally cleaves phosphocholine from sphingomyelin. 6. **Hepatosplenomegaly** — results from accumulation of sphingomyelin in reticuloendothelial cells. ### Mechanism of Pathology ```mermaid flowchart TD A[Sphingomyelinase deficiency]:::outcome --> B[Sphingomyelin accumulation]:::outcome B --> C[Macrophages engorged<br/>Sea-blue histiocytes]:::outcome B --> D[Neuronal storage<br/>CNS degeneration]:::outcome D --> E[Seizures, regression<br/>Cherry-red spot]:::outcome C --> F[Hepatosplenomegaly]:::outcome ``` **Clinical Pearl:** The cherry-red spot is best seen on fundoscopy and is a sign of retinal storage disease. It is NOT specific to Niemann-Pick disease but is a marker of lysosomal accumulation in the retina. **Mnemonic:** **NIEMANN-PICK** = **N**eurodegeneration (Type A), **I**nfancy onset, **E**nzyme (sphingomyelinase), **M**acula (cherry-red spot), **A**ccumulation (sphingomyelin), **N**on-neuronopathic (Type B), **P**rogressive, **I**nfantile, **C**hronic, **K**eratopathy (corneal opacities in some types). ### Differential Diagnosis of Cherry-Red Spot | Disorder | Enzyme Deficiency | Age | CNS | Hepatosplenomegaly | |----------|-------------------|-----|-----|--------------------| | **Niemann-Pick A** | Sphingomyelinase | 3–6 mo | Severe | Yes | | **GM1 gangliosidosis** | β-galactosidase | 3–6 mo | Severe | Yes | | **Sialidosis** | Neuraminidase | Infancy | Severe | Yes | | **Central retinal artery occlusion** | — | Any age | No | No | [cite:Robbins 10e Ch 5; Harrison 21e Ch 356]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.